Figure 2From: Antitumor activity of sorafenib-incorporated nanoparticles of dextran/poly(dl-lactide-co-glycolide) block copolymerTEM images of sorafenib-incorporated nanoparticles. Polymer:drug empty nanoparticle (a), 40:2 (b), 40:5 (c), 40:7 (d) nanoparticles.Back to article page